EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Cancer incidence during the COVID‐19 pandemic by region of residence in Manitoba, Canada: A cancer registry‐based interrupted time series study

Kathleen M Decker iD, Allison Feely, Oliver Bucher, Piotr Czaykowski, Pamela Hebbard, Julian O Kim, Harminder Singh, Maclean Thiessen iD, Marshall Pitz, Grace Musto, Katie Galloway, Pascal Lambert

Cancer Medicine · 2023

DOI: 10.1002/cam4.6698 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Medicine, 2023. Verfasst von Kathleen M Decker und 11 weiteren Autor:innen. Beteiligte Einrichtung: Paul Albrechtsen Research Institute CancerCare Manitoba, Winnipeg, Manitoba, Canada. Hauptthemen laut MEDLINE: COVID-19, Lung Neoplasms, Prostatic Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CIHR, Canadian Institutes of Health Research, CancerCare Manitoba Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Health care in Manitoba, Canada is divided into five regions, each with unique geographies, demographics, health care access, and health status. COVID‐19‐related restrictions and subsequent responses also differed by region. To understand the impact of the pandemic on cancer incidence in the context of these differences, we examined age‐standardized cancer incidence rates by region over time before and after the COVID‐19 pandemic.

Methods

We used a population‐based quasi‐experimental study design, population‐based data, and an interrupted time series analysis to examine the rate of new cancer diagnoses before (January 2015 until December 2019) and after the start of COVID‐19 and the interventions implemented to mitigate its impact (April 2020 until December 2021) by region.

Results

Overall cancer incidence differed by region and remained lower than expected in Winnipeg (4.6% deficit, 447 cases), Prairie Mountain (6.9% deficit, 125 cases), and Southern (13.0% deficit, 238 cases). Southern was the only region that had a significantly higher deficit in cases compared to Manitoba (ratio 0.92, 95% CI 0.86, 0.99). Breast and colorectal cancer incidence decreased at the start of the pandemic in all regions except Northern. Lung cancer incidence decreased in the Interlake‐Eastern region and increased in the Northern region. Prostate cancer incidence increased in Interlake‐Eastern.

Conclusions

The impact of the COVID‐19 pandemic on cancer incidence differed by region. The deficit in the number of cases was largest in the southern region and was highest for breast and prostate cancers. Cancer incidence did not significantly decrease in the most northern, remote region.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Lung NeoplasmsProstatic NeoplasmsMaleHumansIncidenceManitobaPandemicsInterrupted Time Series AnalysisCanadaRegistries

Stichwörter der Autor:innen

COVID-19 pandemiccancerincidenceregion

Autor:innen und Institutionen

  • Paul Albrechtsen Research Institute CancerCare Manitoba, Winnipeg, Manitoba, Canada.
  • Department of Community Health Sciences, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada.
  • Department of Epidemiology and Cancer Registry, CancerCare Manitoba, Winnipeg, Manitoba, Canada.
  • Department of Internal Medicine, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada.
  • Department of Medical Oncology and Hematology, CancerCare Manitoba, Winnipeg, Manitoba, Canada.
  • Department of Surgery, Section of General Surgery, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Manitoba, Canada.

ORCID-Profile: Kathleen M Decker, Maclean Thiessen

Förderung

  • CIHR
  • Canadian Institutes of Health Research
  • CancerCare Manitoba Foundation
  • Research Manitoba

Zitieren

APA

Decker, K. M., Feely, A., Bucher, O., Czaykowski, P., Hebbard, P., Kim, J. O., Singh, H., Thiessen, M., Pitz, M., Musto, G., Galloway, K., & Lambert, P. (2023). Cancer incidence during the COVID‐19 pandemic by region of residence in Manitoba, Canada: A cancer registry‐based interrupted time series study. Cancer Medicine. https://doi.org/10.1002/cam4.6698

Vancouver

Decker KM, Feely A, Bucher O, Czaykowski P, Hebbard P, Kim JO, et al. Cancer incidence during the COVID‐19 pandemic by region of residence in Manitoba, Canada: A cancer registry‐based interrupted time series study. Cancer Medicine. 2023. doi:10.1002/cam4.6698

BibTeX
@article{Decker2023,
  author = {Decker, Kathleen M and Feely, Allison and Bucher, Oliver and Czaykowski, Piotr and Hebbard, Pamela and Kim, Julian O and Singh, Harminder and Thiessen, Maclean and Pitz, Marshall and Musto, Grace and Galloway, Katie and Lambert, Pascal},
  title = {Cancer incidence during the COVID‐19 pandemic by region of residence in Manitoba, Canada: A cancer registry‐based interrupted time series study},
  journal = {Cancer Medicine},
  year = {2023},
  doi = {10.1002/cam4.6698}
}
Kostenlos starten →